The Official Medicare Set Aside Blog And Information Resource

Avinza Extended-Release Capsules No Longer Being Manufactured

Medicare, Medicare Set-Asides, Rx/Pharmacy on July 22, 2015 | Posted by Erin O'Neill, PA-C, JD

The Food and Drug Administration (FDA) has announced that all strengths of Avinza (morphine sulfate) extended release capsules have been discontinued. Avinza is a Schedule II long acting opioid medication indicated for the treatment of severe pain only. Avinza carried a black box warning indicating that misuse could lead to death due to the lack […] Continue

New announcement regarding Hydrocodone combination product coverage changes in Medicare Part D effective for WCMSA proposals

CMS, Medicare Set-Aside Blog, Rx/Pharmacy on November 19, 2014 | Posted by Jean S. Goldstein, JD

On November 19, CMS issued an alert regarding a CMS trend we have been seeing more frequently as related to more frequent physician visits.  The alert specifically refers to action taken by the U.S. Drug Enforcement Administration regarding rescheduling of hydrocodone combination products from C-III controlled substances to C-II controlled substances.  Based on this classification, […] Continue

Zohydro ER – The New Actiq

CMS, Commentary, Medicare Set-Aside Blog, Rx/Pharmacy on April 4, 2014 | Posted by Jennifer Jordan, JD, MSCC

Yesterday MEDVAL did its first MSA evaluation for a California applicant taking Zohydo ER. We were genuinely shocked as this drug was not even expected to hit the market until March so we didn’t really anticipate seeing it included in MSAs until maybe the end of the year, if at all if common sense prevailed. […] Continue

We finally have some guidance on Benzodiazepines and Barbiturates

CMS, Medicare Set-Aside Blog, Rx/Pharmacy on April 9, 2013 | Posted by Jennifer Jordan, JD, MSCC

Yesterday, CMS issued the following alert: On October 2, 2012, the Centers for Medicare & Medicaid Services (CMS) issued a memorandum to Part D Sponsors concerning the transition to Part D Coverage of Benzodiazepines and Barbiturates beginning in 2013. Effective June 1, 2013, all Workers’ Compensation Medicare Set-Aside (WCMSA) proposals submitted to CMS for a […] Continue